Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016
- Posted on 7 October, 2016
SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held last night. The OBN Awards celebrate innovation and achievement across the UK life sciences industry, including emerging to late stage R&D companies as well as life science investors.
Touchlight Genetics, a London-based biotechnology company, has successfully established and patented a revolutionary enzymatic process of DNA amplification. Their success at the OBN Awards was attributed to the development of an innovative, in vitro dual enzyme process, capable of producing DNA at commercial scale and quality.
In sponsoring this award, we are supporting the growth of the UK’s burgeoning synthetic biology industry, a core aim of SynbiCITE.
The 3 finalist companies under consideration for this award were:
- Chain Biotech
- Green Biologics
- Touchlight Genetics
Share this article:
People also read
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...